These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
616 related articles for article (PubMed ID: 27604987)
21. Differentially expressed LncRNAs as potential prognostic biomarkers for glioblastoma. Shao M; Liu W; Wang Y Cancer Genet; 2018 Oct; 226-227():23-29. PubMed ID: 30005851 [TBL] [Abstract][Full Text] [Related]
22. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer. Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558 [TBL] [Abstract][Full Text] [Related]
23. Long non‑coding RNA DLEU1 promotes cell proliferation of glioblastoma multiforme. Wang J; Quan X; Peng D; Hu G Mol Med Rep; 2019 Aug; 20(2):1873-1882. PubMed ID: 31257517 [TBL] [Abstract][Full Text] [Related]
24. [Dysregulation of Long Non-coding RNAs in Glioblastoma Multiforme and Their Study Through Use of Modern Molecular-Genetic Approaches]. Večeřa M; Šána J; Bútová R; Reguli Š; Hermanová M; Křen L; Lipina R; Smrčka M; Slabý O Klin Onkol; 2018; 31(Supplementum1):168-170. PubMed ID: 29808696 [TBL] [Abstract][Full Text] [Related]
25. CLDN5 affects lncRNAs acting as ceRNA dynamics contributing to regulating blood‑brain barrier permeability in tumor brain metastasis. Ma SC; Li Q; Peng JY; Zhouwen JL; Zhang DN; Zhang CB; Jiang WG; Jia W Oncol Rep; 2018 Mar; 39(3):1441-1453. PubMed ID: 29328410 [TBL] [Abstract][Full Text] [Related]
26. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method. Wang H; Liu D; Yang J Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292 [TBL] [Abstract][Full Text] [Related]
27. Identification and characterization of lncRNA mediated transcriptional dysregulation dictates lncRNA roles in glioblastoma. Li Y; Wang Z; Wang Y; Zhao Z; Zhang J; Lu J; Xu J; Li X Oncotarget; 2016 Jul; 7(29):45027-45041. PubMed ID: 26943771 [TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNAs regulate effects of β-crystallin B2 on mouse ovary development. Gao Q; Ren H; Chen M; Niu Z; Tao H; Jia Y; Zhang J; Li W Mol Med Rep; 2016 Nov; 14(5):4223-4231. PubMed ID: 27666820 [TBL] [Abstract][Full Text] [Related]
29. Systems biology of myasthenia gravis, integration of aberrant lncRNA and mRNA expression changes. Luo Z; Li Y; Liu X; Luo M; Xu L; Luo Y; Xiao B; Yang H BMC Med Genomics; 2015 Mar; 8():13. PubMed ID: 25889429 [TBL] [Abstract][Full Text] [Related]
30. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma. Gong Z; Hong F; Wang H; Zhang X; Chen J BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434 [TBL] [Abstract][Full Text] [Related]
31. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma. Zhu D; Fang C; Li X; Geng Y; Li R; Wu C; Jiang J; Wu C Oncotarget; 2017 Apr; 8(14):23228-23236. PubMed ID: 28423571 [TBL] [Abstract][Full Text] [Related]
32. Identification of Immune-Related lncRNA Prognostic Signature and Molecular Subtypes for Glioblastoma. Yu W; Ma Y; Hou W; Wang F; Cheng W; Qiu F; Wu P; Zhang G Front Immunol; 2021; 12():706936. PubMed ID: 34899682 [TBL] [Abstract][Full Text] [Related]
33. Microarray analysis of Long non-coding RNA expression profiles in human gastric cells and tissues with Helicobacter pylori Infection. Zhu H; Wang Q; Yao Y; Fang J; Sun F; Ni Y; Shen Y; Wang H; Shao S BMC Med Genomics; 2015 Dec; 8():84. PubMed ID: 26690385 [TBL] [Abstract][Full Text] [Related]
34. Integrating lncRNAs and mRNAs expression profiles in terminal hindgut of fetal rats with anorectal malformations. Xiao H; Huang R; Chen L; Diao M; Li L Pediatr Surg Int; 2018 Sep; 34(9):971-982. PubMed ID: 30088056 [TBL] [Abstract][Full Text] [Related]
35. Characterization of long noncoding RNA and messenger RNA signatures in melanoma tumorigenesis and metastasis. Wang S; Fan W; Wan B; Tu M; Jin F; Liu F; Xu H; Han P PLoS One; 2017; 12(2):e0172498. PubMed ID: 28225791 [TBL] [Abstract][Full Text] [Related]
36. Microarray expression profiles and bioinformatics analysis of mRNAs, lncRNAs, and circRNAs in the secondary temozolomide-resistant glioblastoma. Zhao C; Gao Y; Guo R; Li H; Yang B Invest New Drugs; 2020 Oct; 38(5):1227-1235. PubMed ID: 31823158 [TBL] [Abstract][Full Text] [Related]
37. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
38. Differential long non‑coding RNA and mRNA expression in differentiated human glioblastoma stem cells. Li H; Li H; Hao Y; Jiao Y; Li Z; Yue H; Xu Z; Wang S; Cao Y; Zhao J Mol Med Rep; 2016 Sep; 14(3):2067-76. PubMed ID: 27432080 [TBL] [Abstract][Full Text] [Related]
39. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines. Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600 [TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of long noncoding RNAs in cumulus cells isolated from PCOS patients. Huang X; Hao C; Bao H; Wang M; Dai H J Assist Reprod Genet; 2016 Jan; 33(1):111-21. PubMed ID: 26650608 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]